UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.12 +0.12 (+0.15%) GOLD FUTURES
2,316.60 +5.60 (+0.24%) DOW
38,249.00 +345.71 (+0.91%) Bitcoin GBP
47,473.10 +477.62 (+1.02%)
Gilead Sciences, Inc. (0QYQ.IL)
IOB - IOB Delayed price. Currency in USD
Add to watchlist
At close: 07:12PM BST
| Previous close | 65.38 |
| Open | 65.54 |
| Bid | 62.22 x N/A |
| Ask | 68.62 x N/A |
| Day's range | 64.91 - 65.75 |
| 52-week range | 64.74 - 87.53 |
| Volume | |
| Avg. volume | 51,015 |
| Market cap | 81.514B |
| Beta (5Y monthly) | 0.35 |
| PE ratio (TTM) | 15.04 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.00 (3.81%) |
| Ex-dividend date | 14 Sept 2023 |
| 1y target est | N/A |
- Zacks
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Deciphera Pharmaceuticals, Inc. (DCPH) and GSK are in focus on acquisition news and Q1 earnings, respectively.
- Insider Monkey
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript April 25, 2024 Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $-1.32, expectations were $-1.49. Gilead Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone, and […]
- Zacks
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
© 2024 Yahoo. All rights reserved.